Panretinal photocoagulation for proliferative diabetic retinopathy: Pattern scan laser versus argon laser

American Journal of Ophthalmology

Volumn 153, Issue 1, 2012, Pages

  Chappelow, Aimee V ^a   Tan, Kevin ^a   Waheed, Nadia K ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; ARGON LASER; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENCE; INTERMETHOD COMPARISON; IRIS DISEASE; LASER; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION OF THE IRIS; PATTERN SCAN LASER; PRIORITY JOURNAL; RACE; RETINA NEOVASCULARIZATION; SEX; TREATMENT OUTCOME; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 83555168267     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.05.035     Document Type: Article

References (16)

1. Preliminary report on effects of photocoagulation therapy The Diabetic Retinopathy Study Research Group Am J Ophthalmol 81 4 1976 383 396
2. S.B. Bressler Does wavelength matter when photocoagulating eyes with macular degeneration or diabetic retinopathy? Arch Ophthalmol 111 2 1993 177 180
3. M.S. Blumenkranz, D. Yellachich, D.E. Andersen Semiautomated patterned scanning laser for retinal photocoagulation Retina 26 3 2006 370 376
4. OptiMedica Corp PASCAL® Benefits http://www.optimedica.com/pascal/ benefits.aspx Accessed: September 26, 2010
5. G. Schuele, M. Rumohr, G. Huettmann, R. Brinkmann RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen Invest Ophthalmol Vis Sci 46 2 2005 714 719
6. S. Al-Hussainy, P.M. Dodson, J.M. Gibson Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times Eye 22 1 2008 96 99
7. A. Jain, M.S. Blumenkranz, Y. Paulus Effect of pulse duration on size and character of the lesion in retinal photocoagulation Arch Ophthalmol 126 1 2008 78 85
8. E. Stefansson Oxygen and diabetic eye disease Graefes Arch Clin Exp Ophthalmol 228 2 1990 120 123
9. C. Flaxel, J. Bradle, T. Acott, J.R. Samples Retinal pigment epithelium produces matrix metalloproteinases after laser treatment Retina 27 5 2007 629 634
10. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization The Krypton Argon Regression Neovascularization Study report number 1 Ophthalmology 100 11 1993 1655 1664
11. F. Bandello, R. Brancato, G. Trabucchi Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time Graefes Arch Clin Exp Ophthalmol 231 9 1993 491 494
12. V. Seiberth, S. Schatanek, E. Alexandridis Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation Graefes Arch Clin Exp Ophthalmol 231 6 1993 318 322
13. A. Mirshahi, R. Roohipoor, A. Lashay Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial Eur J Ophthalmol 18 2 2008 263 269
14. M.F. Cordeiro, M.R. Stanford, P.M. Phillips, J.S. Shilling Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy Eye 11 Pt 4 1997 531 536
15. C. Sanghvi, R. McLauchlan, C. Delgado Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures Br J Ophthalmol 92 8 2008 1061 1064
16. D. Modi, P. Chiranand, L. Akduman Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization Clin Ophthalmol 3 2009 465 470